Cite
Discovery of Norisoboldine Analogue III 11 as a Novel and Potent Aryl Hydrocarbon Receptor Agonist for the Treatment of Ulcerative Colitis.
MLA
Lin, Li, et al. “Discovery of Norisoboldine Analogue III 11 as a Novel and Potent Aryl Hydrocarbon Receptor Agonist for the Treatment of Ulcerative Colitis.” Journal of Medicinal Chemistry, vol. 66, no. 10, May 2023, pp. 6869–88. EBSCOhost, https://doi.org/10.1021/acs.jmedchem.3c00287.
APA
Lin, L., Liu, Y., Chen, L., Dai, Y., & Xia, Y. (2023). Discovery of Norisoboldine Analogue III 11 as a Novel and Potent Aryl Hydrocarbon Receptor Agonist for the Treatment of Ulcerative Colitis. Journal of Medicinal Chemistry, 66(10), 6869–6888. https://doi.org/10.1021/acs.jmedchem.3c00287
Chicago
Lin, Li, Yongmin Liu, Li Chen, Yue Dai, and Yufeng Xia. 2023. “Discovery of Norisoboldine Analogue III 11 as a Novel and Potent Aryl Hydrocarbon Receptor Agonist for the Treatment of Ulcerative Colitis.” Journal of Medicinal Chemistry 66 (10): 6869–88. doi:10.1021/acs.jmedchem.3c00287.